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Are we running out of cardiac surgeons? Demography of cardiac
surgeons in France in 2012
Marc Laskar
CHU Dupuytren, chirurgie cardiovasculaire, Limoges, France
Objective: The aim of the study was to have an exact evaluation of the
inflow and outflow of cardiac surgeons in France.
Methods: The French Society of Thoracic and Cardiovascular Surgery
(SFCTCV) has built a database of the surgeons involved in thoracic and/or car-
diac surgery in France. It includes all the surgeons who do performe cardiac or
thoracic surgery whatever the number of operations performed per year, being
or not member of the SFCTCV, and all the trainees as soon as they have
expressed the will of becoming involved in thoracic and/or cardiac surgery.
Results: The database includes 552 senior surgeons (Professors, staff phy-
sicians, private practitioners) practising cardiac and/or thoracic surgery. 208
practice cardiac, 273 thoracic and 71 both. The “inflow” includes 129 resi-
dents and 75 senior residents.
Global analysis of age distribution shows a mean predictable outflow of
17.3 senior surgeons a year between 2012 and 2021. The “nflow” of senior
residents for the next 5 years is 18 a year. The number of residents is 30 per
year of residency.
Cardiac surgeons “outflow” will be 7.7 a year and the inflow of finishing
senior residents 10 a year. Sex distribution gives evidence of an increasing
feminization. Women’s ratio is 5%, 23% and 31% among senior surgeons,
senior residents, and residents respectively.
Conclusion: France will not run out of cardiothoracic surgeons. The inflow
compensates for the outflow of surgeons liable to stop their activity in the next
ten years.
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Background: Acute aortic syndromes (AAS) represent a wide range of
life-threatening pathologies. We assessed the feasibility and early results of an
immediate, round-the-clock, protocolized management of patients with AAS.
Method: In January 2009, we set up the SOS-Aorta program regrouping
intensivists, cardio-vascular and endovascular surgeons available around the
clock. All patients admitted via SOS-aorta were included in a prospective
registry. We compared the early results of this registry to the one of a retrospec-
tive cohort of patients admitted for AAS before the creation of this program.
Result: From January 2006 to December 2011, a total of 451 patients were
admitted for AAS (174 before and 287 after SOS-Aorta). The average number
of patients treated annually was 58±6.6 in the 3-years before SOS-Aorta. It
increased significantly to 96±17 (p<0.05) after SOS-Aorta. The overall in-hos-
pital mortality in the early period was 36.4±1.84%. It decreased significantly
to 21.6% (p<0.01) after SOS-Aorta. The first 122 patients from the SOS-aorta
registry were reviewed: mean age 66 (56-78), 70% men. Chest or abdominal
pain were present in 68,8%. Typical migrating pain suggestive of aortic dis-
section was present in only 4%. Final diagnosis xas: acute Type A dissection
in 52%, type B in 19% and ruptured aneurysm in 25%. Patients were fre-
quently in critical condition: 25% with shock, 8,2% cardiac arrest, 11% acute
coronary syndrom and 8% tamponade. The mean SAPS2 score (New Simpli-
fied Acute Physiology Score) was 30 [24-37]. 79% of the patients underwent
emergent surgery in a mean time frame of 1,27 hours (0,24-7,63). Multivariate
analysis showed that SAPS2 score was the only significant predictor of mor-
tality OR:1,12 (IC95%:1,05-1,18), p<0,001.
Conclusion: Setting-up the SOS-Aorta program has increased significantly
the number of patients admitted for AAS. It resulted in a significant improve-
ment of in-hospital mortality for these patients with otherwise immediate
severe prognosis.
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Pregnancy Following Aortic Valve Replacement – Cardiac, Maternal
and Fetal Outcomes
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Leduc, Ismail El-Hamamsy
Institut de cardiologie de Montréal, Montréal, Canada
Introduction: The choice of aortic valve substitute in young women
should take the desire for pregnancy into account. Currently however, little is
known about pregnancy-related outcomes following aortic valve replacement
(AVR). The aim of this study was to assess cardiac, maternal and fetal-related
outcomes in female patients with AVR during and after pregnancy.
Method: A retrospective study of all AVRs performed in women under the
age of 40 years at our institution was undertaken. These patients were pro-
spectively followed at our dedicated valve clinic. Patients with Turner syn-
drome or having undergone a hysterectomy and/or tubal ligation were
excluded. Cardiovascular, maternal and fetal outcomes were gathered from
medical records and telephone interviews.
Results: From 1976 to 2011, 77 women underwent 86 isolated AVRs: 65
mechanical prostheses (MPs) and 21 bioprostheses (BPs). The follow-up was
81% complete. Ten patients (13%) had 19 pregnancies at a mean age of 28±6
years. Of those, 5 ended in miscarriages (26%; n=4 BPs and n=1 MPs).
Twelve (63%) pregnancies occurred in patients with BPs. The following
adverse events were reported: two hospitalizations for syncope (25%), func-
tional prosthetic valve deterioration during pregnancy necessitating reinterven-
tion 6 months post-partum (12%) and 4 miscarriages (33%). 
Nine of the 65 women (14%) with MPs had a hysterectomy or endometrial
ablation for excessive uterine bleeding, precluding childbearing potential. In
total, 7 pregnancies were reported in women with MPs. Two of them were ter-
minated (n=1, medical advice and n=1 embolic myocardial infarction). The
following peri-partum complications occurred: two embolic myocardial
infarctions (33%), a postpartum bleeding (16%) and an urgent caesarean for
placental abruption (16%). 
No fetal adverse events were observed.
Conclusion: Findings from this study suggest that pregnancy in women
with prosthetic AVR is associated with an increased risk of cardiac adverse
outcomes.
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Bilateral internal mammary arteries (BIMA) remain still widely underuti-
lized in coronary artery bypass grafting (CABG). This historical cohort study
evaluated the early and long term outcomes of BIMA grafts in isolated CABG
in a single institution.
Methods: Between 1996 and 2008, we performed elective, isolated, pri-
mary, multiple CABG using bilateral internal mammary artery (IMA) grafts
and supplemental venous grafts for multivessel coronary disease in 1000
consecutive patients.
Results: The mean age of the overall population was 64±15 years. 20% of
patients were diabetics with a left ventricular ejection fraction (LVEF) ≤45%
in 28% of patients. Comorbidities were represented by chronic renal failure,
chronic obstructive pulmonary disease and peripheral artery disease in 11%,
11,5% and 26,9% of cases respectively. Acute coronary syndrome represented
the initial clinical presentation in 41% of cases.
The 30-day mortality rate was 2.8%. Early postoperative morbidity included
myocardial infarction (2,2%), stroke (0,9%), mesenteric ischemia (0,7%), ster-
nitis requiring reintervention (6,7%) and supraventricular arrhythmia (23,1%). 
The follow-up (between 3 and 14,8 years; mean follow up: 6,4±5 years)
revealed 103 deaths. Kaplan-Meier 8-year survival rates for patients <65 and
65 to 74 years of age were 88% and 66% respectively (p<0,01). Multiple
regression analysis showed that age ≥ 65 years at baseline (odds ratio (OR):
2,3; 95% confidence interval (CI): 1,3 to 4, p<0,001), acute coronary syn-
drome (OR: 1,9; 95% CI: 1,1 to 3,4, p=0,02), chronic renal failure (OR: 2,7;
95% CI, 1,4 to 5,2, p<0,001), peripheral artery disease (OR: 3,1; 95% CI, 1,8
to 5,5, p<0,001) and LVEF ≤45% (OR: 2,6; 95% CI, 1,4 to 4,5, p<0,001) were
independent predictors of long term cardiovascular mortality.
Conclusion: Our longitudinal analysis demonstrates that bilateral IMA
grafting has a low operative risk and provides excellent long-term survival.
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Background: Asymptomatic carotid artery stenosis (CAS) combined with
coronary artery disease (CAD) remains of special interest to cardiologists and
cardiac surgeons given the fact that coronary artery bypass grafting (CABG)
is one of the most frequent procedures and that CAS cause 30% of all post-
CABG strokes.
Aim: Determining the frequency of asymptomatic CAS in CAD patients
and to what degree the extent of CAD and presence of certain risk factors can
be indicators of CAS in asymptomatic patients.
Methods: Retrospective evaluation of consecutive patients that underwent
CABG during one year in our center whithout present symptoms or signs of
CAS. The pre-operative Doppler ultrasonography was used to determine the
presence and the degree of CAS. Patients were divided according to the pres-
ence of significant CAS. Impact of age, gender, body mass index, presence of
hypertension, diabetes, smoking, cholesterol, triglycerides and three echo-
cardiographic variables obtained from transthoracic echocardiography (the
presence of aortic wall sclerosis, aortic valve sclerosis and mitral valve calci-
fication) were assessed.
Results: Hemodinamically significant asymptomatic CAS was present in
18 patients (7.1%). The risk of presence of CAS was more significant in those
older than 60 years (OR 2.58; 95% CI 0.98-6.77) and in patients with left
main stenosis (OR 8.92; 95% CI 3.2-24.83).
Conclusion: The presence of asymptomatic CAS is strongly associated
with the presence of left main stenosis and an age older than 60. Noninvasive
screening for carotid disease should be done in these subgroups of patients ref-
fered to CABG.
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Background: Brucellosis is the most frequent zoonotic infectious disease
in the world. The most common affected systems are the locomotor, gastroin-
testinal, genitourinary and hematologic. Endocarditis is the most common car-
diovascular manifestation of brucellosis with high mortality rate. Despite
treatment by means of several antibiotic regimens, the relapse is estimated to
occur in 5-40%. Brucella is an intracellular pathogen which makes it inacces-
sible to antibiotics and relapse can occur after a variable period of clinical
latency.
Case report: This is a case report of Brucella mitral valve endocarditis as
a complication of severe relapse of Brucella infection, which was successfully
treated by medical and surgical therapy.
Conclusion: Cardiac involvement in human brucellosis is rare, especially
in relapse, but should not be overlooked, since it is a major mortality cause in
brucellosis infection. The success of Brucella endocarditis treatment depends
on timely and complete medical and epidemiological evaluation, which leads
to adequate medicamentous and surgical treatment of the patient. This
approach would reduce complications and mortality associated with Brucella
endocarditis and would improve patient’s quality of life.
